Rey J W, Heister P, Wirges U, Nadalin S, Breuer R, Niehues T
Department of Internal Medicine I, University Medical Center Mainz, Germany.
Klin Padiatr. 2009 Nov-Dec;221(6):390-2. doi: 10.1055/s-0029-1239528. Epub 2009 Nov 4.
BACKGROUND AND CASE REPORT: The use of organs from donors with central nervous systems (CNS) malignancies is controversial discussed. We present a 1 year old boy, who was admitted for torticollis. A computer tomography detected a large tumor in the posterior cranial fossa. The tumor was resected, but postoperatively a malignant brain swelling occurred, being resistant to standard treatment. After brain death was established and permission was given, organ donation was performed. All grafts showed good initial functions and no complications.
We investigated the evidence for transplantation of organs from donors with central nervous malignancies.
The Australia and New Zealand Combined Dialysis and Transplant Registry, the United Network for Organ Sharing and Hornik et al., reported three transmissions of a glioblastoma multiforme in 958 recipients, who received grafts from donors with CNS tumors. In contrast the Israel Penn International Tumor Registry suggests that transmission is more common: 62 organs were transplanted, 14 cases showed transmission. All cases of medulloblastoma, showing transmission were associated with ventriculoperitoneal shunt. In summary, 1 020 organs of CNS tumors were transplanted, 17 cases were identified with tumors transmission from CNS malignancy.
Organ donors where brain death is established suffering from brain tumors should not be generally regarded as contraindications for an organ transplant. Organs from patients with risk factors (e. g. ventriculoperitoneal shunt) should be excluded from the donor pool as transmission is more likely. The risk of donor transmitted malignancies should be weight against the urgency to receive a transplant graft.
背景与病例报告:使用患有中枢神经系统(CNS)恶性肿瘤的供体器官存在争议。我们报告一名1岁男孩,因斜颈入院。计算机断层扫描发现后颅窝有一个大肿瘤。肿瘤被切除,但术后发生恶性脑肿胀,对标准治疗无效。在确定脑死亡并获得许可后,进行了器官捐献。所有移植物最初功能良好,无并发症。
我们调查了来自患有中枢神经系统恶性肿瘤供体的器官移植证据。
澳大利亚和新西兰联合透析与移植登记处、器官共享联合网络以及霍尼克等人报告,在958名接受来自患有中枢神经系统肿瘤供体移植物的受者中,有3例发生多形性胶质母细胞瘤传播。相比之下,以色列佩恩国际肿瘤登记处表明传播更为常见:62个器官被移植,14例出现传播。所有出现传播的髓母细胞瘤病例均与脑室腹腔分流有关。总之,1020个患有中枢神经系统肿瘤的器官被移植,17例被确定存在中枢神经系统恶性肿瘤的肿瘤传播。
已确定脑死亡且患有脑肿瘤的器官供体一般不应被视为器官移植的禁忌证。有风险因素(如脑室腹腔分流)患者的器官应从供体库中排除,因为传播的可能性更大。供体传播恶性肿瘤的风险应与接受移植移植物的紧迫性相权衡。